Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs

Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs

14-04-2022

The National Growth Fund invests 325 million euros in the Oncode-PACT plan to accelerate the preclinical development process of cancer …

In the media: Rarity – Personalised cancer treatment – fact not fiction

In the media: Rarity – Personalised cancer treatment – fact not fiction

28-02-2022

Imagine a world in which each person’s cancer is treated with a personalised, targeted medical treatment regimen. A world in …

Novel catalog interface Hartwig Medical Database with whole genome sequenced tumor genomes

Novel catalog interface Hartwig Medical Database with whole genome sequenced tumor genomes

22-02-2022

Hartwig Medical Foundation has presented a novel catalog interface of the Hartwig Medical Database with whole genome sequenced tumor genomes: https://catalog.hartwigmedicalfoundation.nl. …

Complete DNA analysis for young adults with cancer

Complete DNA analysis for young adults with cancer

06-01-2022

KWF finances the expansion of the infrastructure for cancer research in young adults with almost 4.5 million euros. These are …

Single WGS analysis of metastases is sufficient in most cases

Single WGS analysis of metastases is sufficient in most cases

26-10-2021

DNA analysis of the tumor is of crucial importance to determine treatment options for patients with metastasized lung cancer. But …

Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs

Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs

10-08-2021

A one-time analysis of the entire tumor DNA is almost always sufficient to find all DNA errors that may be …

Erasmus MC Cancer Institute introduces comprehensive DNA testing for CUP cancer patients in EMBRAZE region

Erasmus MC Cancer Institute introduces comprehensive DNA testing for CUP cancer patients in EMBRAZE region

01-08-2021

The Erasmus MC Cancer Institute has started using comprehensive DNA testing for carcinoma of unknown primary (CUP) cancer patients in …

ASCO 2021: Presentations about whole genome sequencing

ASCO 2021: Presentations about whole genome sequencing

19-06-2021

At the congress of the American Society of Clinical Oncology (ASCO) on 4-8 June 2021 researchers Kris Samsom and Luuk …

New CPoC grant awarded: GLOW – GLioblastoma targeted treatment Option maximisation by WGS

New CPoC grant awarded: GLOW – GLioblastoma targeted treatment Option maximisation by WGS

27-05-2021

Oncode Institute has announced that the 13th grant within the Clinical Proof of Concept programme has been awarded. Oncode Investigator …

Measuring the effects of radiotherapy on cancer may open up avenues for treatment

Measuring the effects of radiotherapy on cancer may open up avenues for treatment

21-05-2021

Radiotherapy works by damaging the DNA of cancer cells. It’s an effective strategy overall, but many cancers have subsets of …

Whole Genome Sequencing for cancer diagnostics clinically validated

Whole Genome Sequencing for cancer diagnostics clinically validated

18-05-2021

Scientific research has demonstrated that Whole Genome Sequencing (WGS) is at least as reliable as routine diagnostic procedures. Clinical Molecular …

In the media: Genomeweb: Partial reimbursement for comprehensive DNA test in the Netherlands

In the media: Genomeweb: Partial reimbursement for comprehensive DNA test in the Netherlands

09-04-2021

This week, Genomeweb’s Precision Oncology News brought the news that the Dutch House of Representatives has recently unanimously decided to …

Back to Latest news

Would you like to be kept up to date with new developments?

Want to know more about the complete DNA test?

Visit OncoAct.nl